Global Sepsis Diagnostics Market Size, Share, Trends and Forecast To 2019-2025

The global sepsis diagnostics market is estimated to grow at a significant CAGR during the forecast period. Sepsis is a major unmet medical need caused by a patient’s overwhelming and life-threatening immune response to infection and can lead to tissue damage, organ failure, and even death. Sepsis affects an estimated 20-30 million people globally every year. According to the Agency for Healthcare Research and Quality, sepsis is the most expensive condition treated in US hospitals, costing more than $20 billion and increasing annually on average by 11.9%.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/sepsis-diagnostics-market

The key players operating in the global sepsis diagnostics market is also driving the market growth. Players such as Abbott Laboratories, Inc., Becton, Dickinson & Co., Biomérieux SA, Bruker Corp., Danaher Corp., F. Hoffmann-La Roche Ltd., Luminex Corp., Qiagen NV, Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., and Trinity Biotech Plc, among others are significantly contributing to the sepsis diagnostics industry growth by adopting various growth strategies. Product launches & developments, partnerships, agreements, and acquisitions are among some of the strategies adopted by the players to sustain in a competitive sepsis diagnostics market globally, during the forecast period.

A Full Report of Global Sepsis Diagnostics Market is Available at: https://www.omrglobal.com/industry-reports/sepsis-diagnostics-market

In April 2019, the Scottish Government along with FEAT - The Fiona Elizabeth Agnew Trust, Sepsis Research center started a campaign across Scotland to create public awareness regarding signs and symptoms of sepsis.

In April 2019, the US FDA approved Beckman Coulter Inc., a Danaher Corp. company for its Early Sepsis Indicator. This indicator is a cellular biomarker designed and enables the identification of patients with sepsis or at high risk of developing the disease.

In August 2018, Sysmex Corp., a Japan-based company introduced its new HISCL Presepsin Assay Kit, for the detection of presepsin, the primary test parameter for bacterial sepsis. This kit aid in the early diagnosis of bacterial sepsis with higher accuracies in comparison with conventional biomarkers.

In May 2018, the US FDA approved T2 Biosystems, Inc., a US-based emerging medical examination solutions company for its T2Bacteria Panel. The novel developed panel is intended for the recognition of specific sepsis-causing bacterial pathogens in human whole blood specimens.

In March 2018, Biocartis Group NV, a molecular diagnostics company and Immunexpress Pty Ltd, a host response molecular diagnostic company, committed to improving clinical and economic outcomes for suspected sepsis patients, today announced that they have entered into a partnership agreement aimed at the development and commercialization of Immunexpress’ SeptiCypte test for use on Biocartis’ sample-to-result Idylla platform.

Global Sepsis Diagnostics Market – Segmentation

By Product Type

Instruments
Assays and Reagents
Other Products

By Technology

Molecular Diagnostics
Immunoassay
Others

By Pathogen

Bacterial Sepsis Diagnostics
Fungal Sepsis Diagnostics
Others

Global Sepsis Diagnostics Market – Segmentation by Region

North America

United States
Canada

Europe

Germany
United Kingdom
France
Spain
Italy
Rest of Europe

Asia-Pacific

China
Japan
India
Rest of Asia-Pacific

Rest of the World

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/sepsis-diagnostics-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.